Type 2 Diabetes and Diabetic Cardiac Autonomic Neuropathy: Identifying High-Risk Patients for Early Intervention

Understanding Diabetic Cardiac Autonomic Neuropathy: A Comprehensive Study

Type 2 diabetes mellitus (T2DM), the most prevalent form of diabetes, affects millions of adults worldwide. A serious complication of T2DM, diabetic cardiac autonomic neuropathy (DCAN), often goes unnoticed in its early stages, leading to severe consequences like arrhythmias and sudden cardiac death. Early identification and intervention are crucial to mitigate the risks associated with DCAN. This study examines the factors contributing to DCAN and highlights the importance of skin advanced glycation end products (AGEs) as potential biomarkers.

Study Details

Participants and Methodology

This research involved 192 T2DM patients admitted to the Department of Endocrinology at Hefei Second People’s Hospital from November 2020 to December 2022. The participants, aged between 18 and 75, were divided into two groups based on the Ewing test results: those with DCAN (121 patients) and those without (71 patients). The study excluded patients with certain conditions that could affect heart rate or complicate the tests.

Data on age, sex, blood pressure, height, weight, and other biochemical markers were collected. The Ewing test, a standardized method to assess autonomic nerve function, was conducted on all participants. Additionally, skin AGE levels were measured using a non-invasive detector to compare between the two groups.

Finding Key Insights

General Data and Biochemical Indices

Compared to the No_DCAN group, the DCAN group exhibited higher levels of combined diabetic retinopathy (DR), fasting plasma glucose (FPG), and skin AGEs. These findings suggest a significant correlation between these factors and the presence of DCAN.

A multivariate logistic regression analysis identified FPG, combined DR, and skin AGEs as independent risk factors for DCAN. The results indicated that higher levels of these factors significantly increased the likelihood of DCAN.

Table 2 Multi-Factor Logistic Regression Analysis of DCAN Influencing Factors

Skin AGE Correlation

Further analysis using Spearman and Pearson correlation coefficients revealed that skin AGE accumulation was significantly associated with factors like FPG and combined DR in patients with DCAN. These correlations highlight the value of skin AGEs as potential biomarkers for DCAN.

Table 3 Spearman Correlation Analysis of Skin AGE Accumulation Factors

Table 4 Pearson Correlation Analysis of Skin AGE Accumulation Factors

Implications and Future Research

The findings of this study underscore the importance of early detection and intervention in managing DCAN. Measuring skin AGEs could provide a non-invasive and cost-effective method to identify high-risk patients with T2DM. Future research should explore potential treatments that could reduce skin AGE levels and their impact on preventingonomic function in diabetes.

Conclusion

In summary, this research highlights the relationships between DCAN, combined DR, FPG, and skin AGEs in T2DM patients. Identifying these risk factors can help healthcare providers develop more effective strategies for preventing the progression of DCAN and improving patient outcomes. Early diagnosis and management are key to mitigating the risks associated with this serious complication of diabetes.

Through continued research and advancements in diagnostic techniques, healthcare professionals can better understand and treat DCAN, ultimately improving the quality of life for individuals with T2DM.